A pilot study of cystic fibrosis exacerbation response phenotypes reveals contrasting serum and sputum iron trends

Abstract The cystic fibrosis (CF) community seeks to explain heterogeneous outcomes of pulmonary exacerbation (PEX) treatment. Serum and sputum inflammatory mediators may identify people with CF (PwCF) at risk for suboptimal responses. However, lack of an established association between response phe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alex H. Gifford, Deepika Polineni, Jianghua He, Jessica L. D’Amico, Dana B. Dorman, Molly A. Williams, Amanda B. Nymon, Akshu Balwan, Theodore Budden, Jonathan B. Zuckerman
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ff206a3200c9407398acb1339e5aa7c6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ff206a3200c9407398acb1339e5aa7c6
record_format dspace
spelling oai:doaj.org-article:ff206a3200c9407398acb1339e5aa7c62021-12-02T15:53:59ZA pilot study of cystic fibrosis exacerbation response phenotypes reveals contrasting serum and sputum iron trends10.1038/s41598-021-84041-y2045-2322https://doaj.org/article/ff206a3200c9407398acb1339e5aa7c62021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-84041-yhttps://doaj.org/toc/2045-2322Abstract The cystic fibrosis (CF) community seeks to explain heterogeneous outcomes of pulmonary exacerbation (PEX) treatment. Serum and sputum inflammatory mediators may identify people with CF (PwCF) at risk for suboptimal responses. However, lack of an established association between response phenotypes and these mediators limits clinical application. In this pilot study, we prospectively characterized treatment response phenotypes by assessing health-related quality-of-life (HRQoL) during PEX. We also measured lung function and iron-related biochemical parameters in serum and sputum. We classified subjects as sustained symptom-responders (SRs) or non-sustained symptom-responders (NSRs) based on the absence or presence, respectively, of worsened symptom scores after initial improvement. We used linear mixed models (LMMs) to determine whether trends in lung function, hematologic, serum, and sputum indices of inflammation differed between response cohorts. In 20 PwCF, we identified 10 SRs and 10 NSRs with no significant differences in lung function at PEX onset and treatment durations. SRs had better model-predicted trends in lung function than NSRs during PEX. Non-linear trends in serum and sputum iron levels significantly differed between SRs and NSRs. In adults with cystic fibrosis, PEX treatment response phenotypes may be correlated with distinctive trends in serum and sputum iron concentrations.Alex H. GiffordDeepika PolineniJianghua HeJessica L. D’AmicoDana B. DormanMolly A. WilliamsAmanda B. NymonAkshu BalwanTheodore BuddenJonathan B. ZuckermanNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Alex H. Gifford
Deepika Polineni
Jianghua He
Jessica L. D’Amico
Dana B. Dorman
Molly A. Williams
Amanda B. Nymon
Akshu Balwan
Theodore Budden
Jonathan B. Zuckerman
A pilot study of cystic fibrosis exacerbation response phenotypes reveals contrasting serum and sputum iron trends
description Abstract The cystic fibrosis (CF) community seeks to explain heterogeneous outcomes of pulmonary exacerbation (PEX) treatment. Serum and sputum inflammatory mediators may identify people with CF (PwCF) at risk for suboptimal responses. However, lack of an established association between response phenotypes and these mediators limits clinical application. In this pilot study, we prospectively characterized treatment response phenotypes by assessing health-related quality-of-life (HRQoL) during PEX. We also measured lung function and iron-related biochemical parameters in serum and sputum. We classified subjects as sustained symptom-responders (SRs) or non-sustained symptom-responders (NSRs) based on the absence or presence, respectively, of worsened symptom scores after initial improvement. We used linear mixed models (LMMs) to determine whether trends in lung function, hematologic, serum, and sputum indices of inflammation differed between response cohorts. In 20 PwCF, we identified 10 SRs and 10 NSRs with no significant differences in lung function at PEX onset and treatment durations. SRs had better model-predicted trends in lung function than NSRs during PEX. Non-linear trends in serum and sputum iron levels significantly differed between SRs and NSRs. In adults with cystic fibrosis, PEX treatment response phenotypes may be correlated with distinctive trends in serum and sputum iron concentrations.
format article
author Alex H. Gifford
Deepika Polineni
Jianghua He
Jessica L. D’Amico
Dana B. Dorman
Molly A. Williams
Amanda B. Nymon
Akshu Balwan
Theodore Budden
Jonathan B. Zuckerman
author_facet Alex H. Gifford
Deepika Polineni
Jianghua He
Jessica L. D’Amico
Dana B. Dorman
Molly A. Williams
Amanda B. Nymon
Akshu Balwan
Theodore Budden
Jonathan B. Zuckerman
author_sort Alex H. Gifford
title A pilot study of cystic fibrosis exacerbation response phenotypes reveals contrasting serum and sputum iron trends
title_short A pilot study of cystic fibrosis exacerbation response phenotypes reveals contrasting serum and sputum iron trends
title_full A pilot study of cystic fibrosis exacerbation response phenotypes reveals contrasting serum and sputum iron trends
title_fullStr A pilot study of cystic fibrosis exacerbation response phenotypes reveals contrasting serum and sputum iron trends
title_full_unstemmed A pilot study of cystic fibrosis exacerbation response phenotypes reveals contrasting serum and sputum iron trends
title_sort pilot study of cystic fibrosis exacerbation response phenotypes reveals contrasting serum and sputum iron trends
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/ff206a3200c9407398acb1339e5aa7c6
work_keys_str_mv AT alexhgifford apilotstudyofcysticfibrosisexacerbationresponsephenotypesrevealscontrastingserumandsputumirontrends
AT deepikapolineni apilotstudyofcysticfibrosisexacerbationresponsephenotypesrevealscontrastingserumandsputumirontrends
AT jianghuahe apilotstudyofcysticfibrosisexacerbationresponsephenotypesrevealscontrastingserumandsputumirontrends
AT jessicaldamico apilotstudyofcysticfibrosisexacerbationresponsephenotypesrevealscontrastingserumandsputumirontrends
AT danabdorman apilotstudyofcysticfibrosisexacerbationresponsephenotypesrevealscontrastingserumandsputumirontrends
AT mollyawilliams apilotstudyofcysticfibrosisexacerbationresponsephenotypesrevealscontrastingserumandsputumirontrends
AT amandabnymon apilotstudyofcysticfibrosisexacerbationresponsephenotypesrevealscontrastingserumandsputumirontrends
AT akshubalwan apilotstudyofcysticfibrosisexacerbationresponsephenotypesrevealscontrastingserumandsputumirontrends
AT theodorebudden apilotstudyofcysticfibrosisexacerbationresponsephenotypesrevealscontrastingserumandsputumirontrends
AT jonathanbzuckerman apilotstudyofcysticfibrosisexacerbationresponsephenotypesrevealscontrastingserumandsputumirontrends
AT alexhgifford pilotstudyofcysticfibrosisexacerbationresponsephenotypesrevealscontrastingserumandsputumirontrends
AT deepikapolineni pilotstudyofcysticfibrosisexacerbationresponsephenotypesrevealscontrastingserumandsputumirontrends
AT jianghuahe pilotstudyofcysticfibrosisexacerbationresponsephenotypesrevealscontrastingserumandsputumirontrends
AT jessicaldamico pilotstudyofcysticfibrosisexacerbationresponsephenotypesrevealscontrastingserumandsputumirontrends
AT danabdorman pilotstudyofcysticfibrosisexacerbationresponsephenotypesrevealscontrastingserumandsputumirontrends
AT mollyawilliams pilotstudyofcysticfibrosisexacerbationresponsephenotypesrevealscontrastingserumandsputumirontrends
AT amandabnymon pilotstudyofcysticfibrosisexacerbationresponsephenotypesrevealscontrastingserumandsputumirontrends
AT akshubalwan pilotstudyofcysticfibrosisexacerbationresponsephenotypesrevealscontrastingserumandsputumirontrends
AT theodorebudden pilotstudyofcysticfibrosisexacerbationresponsephenotypesrevealscontrastingserumandsputumirontrends
AT jonathanbzuckerman pilotstudyofcysticfibrosisexacerbationresponsephenotypesrevealscontrastingserumandsputumirontrends
_version_ 1718385489124261888